Literature DB >> 835463

The effect of propranolol on hemolysis in patients with an aortic prosthetic valve.

J T Santinga, J D Flora, J B Rush, J A Penner, P W Willis.   

Abstract

Propranolol was given to five patients with severe hemolytic anemia from arotic prostheses. Red cell survival, lactic dehydrogenase, serum hemoglobin, and 24 hour urine iron values were used to evaluate the severity of hemolysis with and without propranolol treatment. Three patients had a clear decrease in the level of hemolysis with propranolol therapy. One patient developed congestive failure after 6 months on propranolol. The decrease in hemolysis is most likely related to a slower heart rate.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 835463     DOI: 10.1016/s0002-8703(77)80311-6

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  4 in total

1.  Amelioration of cardiac hemolytic anemia by sulfinpyrazone therapy.

Authors:  J Owen; A M Seidenfeld; M F Glynn
Journal:  Can Med Assoc J       Date:  1980-03-08       Impact factor: 8.262

Review 2.  Paravalvular Leaks-From Diagnosis to Management.

Authors:  Samuel Bernard; Evin Yucel
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-14

Review 3.  Cardiac prostheses-related hemolytic anemia.

Authors:  Mohamad Alkhouli; Ali Farooq; Ronald S Go; Sudarshan Balla; Chalak Berzingi
Journal:  Clin Cardiol       Date:  2019-05-06       Impact factor: 2.882

4.  Renal hemosiderosis secondary to intravascular hemolysis after mitral valve repair: A case report.

Authors:  In Hee Lee; Gun Woo Kang; Chang-Yeon Kim; Sun-Jae Lee; Min-Kyung Kim; Dong Jik Ahn
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.